Please wait while the formulary information is being retrieved.
QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE)
- Maintenance therapy for asthma
40 mcg/actuation HFA breath activated aerosol
- Inhale 2 puffs (80 mcg) by inhalation route 2 times per day
80 mcg/actuation HFA breath activated aerosol
- Inhale 2 puffs (160 mcg) by inhalation route 2 times per day
Maintenance therapy for asthma
- Inhale 1 puff (40 mcg) by inhalation route 2 times per day
- Inhale 1 puff (80 mcg) by inhalation route 2 times per day
- Inhale 2 puffs (80 mcg) by inhalation route 2 times per day
- Inhale 3 puffs (120 mcg) by inhalation route 2 times per day
- Inhale 2 puffs (160 mcg) by inhalation route 2 times per day
- Inhale 4 puffs (160 mcg) by inhalation route 2 times per day
- Inhale 3 puffs (240 mcg) by inhalation route 2 times per day
- Inhale 4 puffs (320 mcg) by inhalation route 2 times per day
- None
Contraindicated
- Korlym
- Mifeprex
- mifepristone
Severe
Moderate
- Avelox
- Avelox Abc Pack
- Avelox In Nacl (iso-osmotic)
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- Levaquin
- Levaquin In 5 % Dextrose
- levofloxacin
- levofloxacin in D5W
- moxifloxacin
- moxifloxacin in NaCl (iso-osm)
- norfloxacin
- Noroxin
- ofloxacin
- None
Contraindicated
- Active tuberculosis
- Inactive tuberculosis
- Measles contact
- Ocular herpes simplex
- Ocular hypertension
- Parasitic infection
- Varicella contact
Severe
Moderate
- Adrenocortical insufficiency
- Cataracts
- Glaucoma
- Osteoporosis
QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE)
- Maintenance therapy for asthma
- None
- Headache disorder
- Oropharyngeal candidiasis
- Pain in oropharynx
- Pharyngitis
- Upper respiratory infection
- Xerostomia
More Frequent
Severe
Less Severe
- None
- Cough
- Dysgeusia
- Dysmenorrhea
- Nausea
- Pain
- Sinusitis
- Voice change
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenocortical insufficiency
- Angioedema
- Central serous chorioretinopathy
- Glaucoma
- Hypersensitivity drug reaction
- Immunosuppression
- Osteopenia
- Paradoxical bronchospasm
- Suicidal ideation
- Urticaria
Less Severe
- Aggressive behavior
- Blurred vision
- Cataracts
- Depression
- Ocular hypertension
- Skin rash
- Sleep disorder
Contraindicated
None
Severe Precaution
Beclomethasone (select breath-act)
Not recommended age < 4 years. Growth velocity may be decreased in pediatrics
- 1 Day – 4 Years
- Not recommended age < 4 years. Growth velocity may be decreased in pediatrics
Management or Monitoring Precaution
Beclomethasone (select breath-act)
Monitor growth. Velocity may be decreased. Rare reports of behavioral and psychiatric adverse effects, suicidal ideation.
- 4 Years – 18 Years
- Monitor growth. Velocity may be decreased. Rare reports of behavioral and psychiatric adverse effects, suicidal ideation.
Beclomethasone Dipropionate (inhal,nasal)
- Severity Level:
2
- Additional Notes: Current evidence supports use of inhaled corticosteroids for asthma tx in preg
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Beclomethasone Dipropionate
May cause adverse effects if excreted. systemic forms are excreted.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | May cause adverse effects if excreted. systemic forms are excreted. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Beclomethasone
Prolonged high dose increases risk of diabetes, osteoporosis
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Maintenance therapy for asthma | |
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.909 | Unspecified asthma, uncomplicated |
| 0-9 | A-Z |
|---|---|
| J45 | Asthma |
| J45.2 | Mild intermittent asthma |
| J45.20 | Mild intermittent asthma, uncomplicated |
| J45.3 | Mild persistent asthma |
| J45.30 | Mild persistent asthma, uncomplicated |
| J45.4 | Moderate persistent asthma |
| J45.40 | Moderate persistent asthma, uncomplicated |
| J45.5 | Severe persistent asthma |
| J45.50 | Severe persistent asthma, uncomplicated |
| J45.9 | Other and unspecified asthma |
| J45.90 | Unspecified asthma |
| J45.909 | Unspecified asthma, uncomplicated |
Formulary Reference Tool